GNL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.940600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.791400E-01
Normal-vs-Stage2
6.070000E-01
Normal-vs-Stage3
4.185600E-01
Normal-vs-Stage4
1.826340E-02
Stage1-vs-Stage2
2.385800E-01
Stage1-vs-Stage3
5.374000E-01
Stage1-vs-Stage4
5.815600E-03
Stage2-vs-Stage3
1.309590E-01
Stage2-vs-Stage4
1.674170E-01
Stage3-vs-Stage4
2.466000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.760800E-01
Normal-vs-AfricanAmerican
8.927000E-01
Normal-vs-Asian
7.097600E-01
Caucasian-vs-AfricanAmerican
7.008600E-01
Caucasian-vs-Asian
9.143400E-01
AfricanAmerican-vs-Asian
7.936400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.448400E-01
Normal-vs-Female
6.257400E-01
Male-vs-Female
4.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.623200E-01
Normal-vs-Age(41-60Yrs)
4.845200E-01
Normal-vs-Age(61-80Yrs)
7.926600E-01
Normal-vs-Age(81-100Yrs)
6.913000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.594030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.997400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.494800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.359900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.169600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.511000E-01
Normal-vs-Daily Drinker
8.930600E-01
Normal-vs-Weekly Drinker
5.721000E-01
Normal-vs-Occasional Drinker
4.737200E-01
Normal-vs-Social Drinker
5.896400E-01
Non Drinker-vs-Daily Drinker
8.966200E-01
Non Drinker-vs-Weekly Drinker
4.283600E-01
Non Drinker-vs-Occasional Drinker
3.618000E-01
Non Drinker-vs-Social Drinker
6.235600E-01
Daily Drinker-vs-Weekly Drinker
3.809400E-01
Daily Drinker-vs-Occasional Drinker
3.057400E-01
Daily Drinker-vs-Social Drinker
5.392400E-01
Weekly Drinker-vs-Occasional Drinker
9.844800E-01
Weekly Drinker-vs-Social Drinker
7.326400E-01
Occasional Drinker-vs-Social Drinker
6.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.537800E-01
Normal-vs-Grade 2
9.871800E-01
Normal-vs-Grade 3
9.914200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.299400E-03
Grade 1-vs-Grade 3
1.497780E-02
Grade 1-vs-Grade 4
8.537800E-01
Grade 2-vs-Grade 3
6.365600E-01
Grade 2-vs-Grade 4
9.871800E-01
Grade 3-vs-Grade 4
9.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.296400E-01
Normal-vs-NonDiabetic
7.839400E-01
Diabetic-vs-NonDiabetic
9.517600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.208800E-01
Normal-vs-NoPancreatitis
7.822600E-01
Pancreatitis-vs-NoPancreatitis
9.545400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.876200E-01
Normal-vs-N1
6.454200E-01
N0-vs-N1
8.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.196470E-02
Normal-vs-TP53-NonMutant
6.338200E-01
TP53-Mutant-vs-TP53-NonMutant
5.004200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
